Nazira Amra MD, MBA

Nazira Amra is a trained physician and experienced pharmaceutical commercial leader who has spent the last 20+ years working at the intersection of both strategy and operations in both big and small pharma, delivering results in product launch as well as at later stages of the product life cycle across developed and emerging markets. Prior to founding her own strategic consultancy firm, BeeSpoke Strategy, Nazira served as Vice President of Global Commercial Strategy at Intercept Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver disease. She has held numerous senior leadership positions spanning over 14 years at Sanofi. As Head of Operations, Central and West Africa, Dr. Amra led Sanofi's business efforts in 20 countries with oversight of over 300 employees and 100M€ in turnover. Additionally, she served as Sanofi's Vice President Global Launch Preparation Unit where she was responsible for providing a full range of global commercial support to successfully launch new biologics (Otamixaban, sarilumab, and anti-IL4) from Phase IIb onwards. As VP of Global Strategy, Cardio Thrombosis, she led a cross- functional unit responsible for the global strategic direction of Multaq, a product she launched globally, Lovenox, as well as pipeline assets Otamixaban and Semuloparin. Dr. Amra started her career at Sanofi in global product management for Plavix, which became one of the most successful blockbusters in the industry. Nazira holds a BsC in Biology with Honors and an MD from McGill University and an MBA from INSEAD.